These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 18355237)
1. Diagnosis and treatment of lower urinary tract symptoms suggestive of overactive bladder and bladder outlet obstruction among men in general practice in the UK. Morant SV; Reilly K; Bloomfield GA; Chapple C Int J Clin Pract; 2008 May; 62(5):688-94. PubMed ID: 18355237 [TBL] [Abstract][Full Text] [Related]
2. Occurrence of overactive bladder in patients with benign prostatic hyperplasia in the Czech Republic. Hanuš T; Zámečník L; Doležal T; Karmazínová Z Urol Int; 2011; 86(4):407-13. PubMed ID: 21454947 [TBL] [Abstract][Full Text] [Related]
3. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. Irwin DE; Kopp ZS; Agatep B; Milsom I; Abrams P BJU Int; 2011 Oct; 108(7):1132-8. PubMed ID: 21231991 [TBL] [Abstract][Full Text] [Related]
4. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms. Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995 [TBL] [Abstract][Full Text] [Related]
5. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial. Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853 [TBL] [Abstract][Full Text] [Related]
6. The role of antimuscarinics in the management of men with symptoms of overactive bladder associated with concomitant bladder outlet obstruction: an update. Athanasopoulos A; Chapple C; Fowler C; Gratzke C; Kaplan S; Stief C; Tubaro A Eur Urol; 2011 Jul; 60(1):94-105. PubMed ID: 21497434 [TBL] [Abstract][Full Text] [Related]
7. Increased sexual dysfunction in men with storage and voiding lower urinary tract symptoms. Morant S; Bloomfield G; Vats V; Chapple C J Sex Med; 2009 Apr; 6(4):1103-1110. PubMed ID: 19138377 [TBL] [Abstract][Full Text] [Related]
8. A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder. Chapple CR; Roehrborn CG Eur Urol; 2006 Apr; 49(4):651-8. PubMed ID: 16530611 [TBL] [Abstract][Full Text] [Related]
9. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment. Jiang YH; Wang CC; Kuo HC PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145 [TBL] [Abstract][Full Text] [Related]
10. [Differential diagnosis and therapy examined under the microscope. LUTS (lower urinary tract symptoms) due to OAB (overactive bladder) - a frequent disease picture in the man]. MMW Fortschr Med; 2011 Mar; 153(13):44-5. PubMed ID: 21638816 [No Abstract] [Full Text] [Related]
11. Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia. Kang M; Kim M; Choo MS; Bae J; Ku JH; Yoo C; Oh SJ Urology; 2014 Dec; 84(6):1461-6. PubMed ID: 25432841 [TBL] [Abstract][Full Text] [Related]
12. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775 [TBL] [Abstract][Full Text] [Related]
13. Overactive bladder symptoms and voiding dysfunction in neurologically normal women. Espuña-Pons M; Cardozo L; Chapple C; Sievert KD; van Kerrebroeck P; Kirby MG Neurourol Urodyn; 2012 Apr; 31(4):422-8. PubMed ID: 22419262 [TBL] [Abstract][Full Text] [Related]
14. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Irwin DE; Milsom I; Hunskaar S; Reilly K; Kopp Z; Herschorn S; Coyne K; Kelleher C; Hampel C; Artibani W; Abrams P Eur Urol; 2006 Dec; 50(6):1306-14; discussion 1314-5. PubMed ID: 17049716 [TBL] [Abstract][Full Text] [Related]
15. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Liu HT; Kuo HC Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272 [TBL] [Abstract][Full Text] [Related]
16. The use of mono- and combination drug therapy in men and women with lower urinary tract symptoms (LUTS) in the UK: a retrospective observational study. Ali M; Landeira M; Covernton PJO; Choudhury N; Jaggi A; Fatoye F; van Maanen R BMC Urol; 2021 Sep; 21(1):119. PubMed ID: 34474675 [TBL] [Abstract][Full Text] [Related]
17. Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. Lee JY; Kim HW; Lee SJ; Koh JS; Suh HJ; Chancellor MB BJU Int; 2004 Oct; 94(6):817-20. PubMed ID: 15476515 [TBL] [Abstract][Full Text] [Related]
18. Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction. Nitti VW; Rosenberg S; Mitcheson DH; He W; Fakhoury A; Martin NE J Urol; 2013 Oct; 190(4):1320-7. PubMed ID: 23727415 [TBL] [Abstract][Full Text] [Related]
19. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms? Cornu JN; Grise P Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877 [TBL] [Abstract][Full Text] [Related]
20. Bladder outlet obstruction (BOO) in men with castration-resistant prostate cancer. Rom M; Waldert M; Schatzl G; Swietek N; Shariat SF; Klatte T BJU Int; 2014 Jul; 114(1):62-6. PubMed ID: 24053594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]